Literature DB >> 11341431

The extent of osteocyte death in the proximal femur of patients with osteonecrosis of the femoral head.

J D Calder1, M F Pearse, P A Revell.   

Abstract

Our aim was to assess the local extent of osteocyte death in the proximal femur of 16 patients with osteonecrosis of the femoral head. We performed histological examination of the femoral heads and cancellous bone biopsies from four regions of the proximal femur in patients undergoing total hip arthroplasty. A control group consisted of 19 patients with osteoarthritis. All histological specimens were examined in a blinded fashion. Extensive osteonecrosis was shown in the proximal femur up to 4 cm below the lesser trochanter in the group with osteonecrosis. There was an overall statistically significant difference in the extent of osteocyte death distal to the femoral head between the two groups (p < 0.001). We discuss the implications of these findings as possible contributing factors in regard to the early failure of total hip arthroplasty reported in patients with osteonecrosis of the femoral head.

Entities:  

Mesh:

Year:  2001        PMID: 11341431     DOI: 10.1302/0301-620x.83b3.10793

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  15 in total

1.  Treating osteonecrosis with autologous bone marrow cells.

Authors:  Valérie Gangji; Jean-Philippe Hauzeur
Journal:  Skeletal Radiol       Date:  2010-03       Impact factor: 2.199

2.  Prediction of osteonecrosis collapse of the femoral head based on the proportion of the proximal sclerotic rim.

Authors:  Tong Yu; Limin Xie; Zhennan Zhang; Xun Ke; Yang Liu
Journal:  Int Orthop       Date:  2014-11-27       Impact factor: 3.075

3.  Arthroplasty in patients with extensive femoral head avascular necrosis: Cementless arthroplasty in extensive femoral head necrosis.

Authors:  Yu-Hang Gao; Shu-Qiang Li; Yun-Feng Wang; Chen Yang; Jian-Guo Liu; Xin Qi
Journal:  Int Orthop       Date:  2015-02-18       Impact factor: 3.075

4.  Repairing defect and preventing collapse of femoral head in a steroid-induced osteonecrotic of femoral head animal model using strontium-doped calcium polyphosphate combined BM-MNCs.

Authors:  Pengde Kang; Xiaowei Xie; Zhen Tan; Jing Yang; Bin Shen; Zongke Zhou; Fuxing Pei
Journal:  J Mater Sci Mater Med       Date:  2015-01-30       Impact factor: 3.896

5.  Metal-on-metal hip arthroplasty does equally well in osteonecrosis and osteoarthritis.

Authors:  Manish R Dastane; William T Long; Zhinian Wan; Lisa Chao; Lawrence D Dorr
Journal:  Clin Orthop Relat Res       Date:  2008-03-19       Impact factor: 4.176

6.  Infusion, core decompression, or infusion following core decompression in the treatment of bone edema syndrome and early avascular osteonecrosis of the femoral head.

Authors:  Johannes Beckmann; Thorsten Schmidt; Jens Schaumburger; Björn Rath; Christian Lüring; Markus Tingart; Joachim Grifka
Journal:  Rheumatol Int       Date:  2012-12-23       Impact factor: 2.631

7.  Phases 1-3 clinical trials using adult stem cells in osteonecrosis and nonunion fractures.

Authors:  Jean-Philippe Hauzeur; Valérie Gangji
Journal:  Stem Cells Int       Date:  2010-10-26       Impact factor: 5.443

8.  Administration of erythropoietin exerts protective effects against glucocorticoid-induced osteonecrosis of the femoral head in rats.

Authors:  Sen Chen; Jianping Li; Hao Peng; Jianlin Zhou; Hongsong Fang
Journal:  Int J Mol Med       Date:  2014-02-05       Impact factor: 4.101

9.  Region specific Raman spectroscopy analysis of the femoral head reveals that trabecular bone is unlikely to contribute to non-traumatic osteonecrosis.

Authors:  Tristan Pascart; Guillaume Falgayrac; Henri Migaud; Jean-François Quinchon; Laurène Norberciak; Jean-François Budzik; Julien Paccou; Anne Cotten; Guillaume Penel; Bernard Cortet
Journal:  Sci Rep       Date:  2017-03-07       Impact factor: 4.379

10.  Percutaneous implantation of autologous bone marrow osteoprogenitor cells as treatment of bone avascular necrosis related to sickle cell disease.

Authors:  Philippe Hernigou; Gilsasio Daltro; Paolo Filippini; Martin Mukisi Mukasa; Olivier Manicom
Journal:  Open Orthop J       Date:  2008-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.